Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2006, p. 6157-6169, Vol. 26, No. 16
0270-7306/06/$08.00+0 doi:10.1128/MCB.00595-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582,1 CREST, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012,Japan2
Received 6 April 2006/ Returned for modification 22 May 2006/ Accepted 6 June 2006
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Cul7 was originally identified as p185, a protein that binds the large T antigen of simian virus 40 (24). The interaction of p185 with large T antigen is important for the cellular transformation activity of the latter (2), and the BH3 domain identified in the COOH-terminal region of p185 is thought to function in the promotion of apoptosis (36). More recently, p185 was isolated as a protein that binds Rbx1 and which contains a COOH-terminal cullin homology domain; it was thus named Cul7 (11). Cul7 possesses ubiquitylation activity in vitro and interacts with the F-box protein Fbxw8 (also known as Fbw6 or Fbx29), which was identified as a Cul7-binding protein by "pull-down" analysis with Cul7 (11). Fbxw8 is thus not only the receptor component of an SCF (Skp1, Cul1, F-box protein, Rbx1)-type E3 complex but is also the only F-box protein known to interact with Cul7 (4, 11). Cul7 does not interact directly with Skp1 but does so indirectly in an Fbxw8-dependent manner. Fbxw8 appears to interact with Cul7 with a higher affinity than it does with Cul1.
Mice deficient in Cul7 exhibit intrauterine growth retardation as a result of abnormal development of the placenta, characterized by impaired formation of the spongiotrophoblast layer and of vessels in the labyrinth layer, and they die from respiratory distress soon after birth (4). In addition, Fbxw8 is unstable, and its expression is reduced to below detectable levels in Cul7/ cells, with this phenotype being normalized by forced expression of exogenous Cul7. Cul7 is thus thought to play an important role in stabilization of Fbxw8 as well as in the normal development of the placenta and embryo. Cul7 mutations were recently identified in several pedigrees of 3-M syndrome, an autosomal recessive form of hereditary dwarfism characterized by pre- and postnatal growth retardation without mental or endocrine disorders, suggesting that Cul7 is also indispensable for normal human growth (18).
It has remained unclear whether Fbxw8 is the only substrate recognition subunit of the Cul7-based SCF-like complex. To reveal the physiological roles of Fbxw8 and its corresponding E3 complexes, we have generated mice deficient in this protein. We now show that the phenotype of Fbxw8/ mice is similar to that of Cul7/ mice, especially with regard to growth retardation and placental abnormality. However, other characteristics of Cul7/ mice are not apparent in Fbxw8/ mice, suggesting that the Cul7-based SCF-like complex has both Fbxw8-dependent and Fbxw8-independent functions. Moreover, we found that Cul7 forms a complex with Cul1 in an Fbxw8-dependent manner. Our data thus suggest that the newly identified Cul1-Fbxw8-Cul7 complex plays an important role in the normal development of the placenta.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Histological analysis. Tissue was fixed with 4% paraformaldehyde in phosphate-buffered saline, embedded in paraffin, and sectioned at a thickness of 3 µm. Hematoxylin-eosin staining was performed as described previously (27). Sixteen different fields (magnification, ×200) were randomly selected for measurement of the mean areas of maternal and fetal vessels in the placenta with the use of SCION Image software. For immunofluorescence, samples were fixed with 4% paraformaldehyde in phosphate-buffered saline, embedded in OCT compound (Tissue Tek), and sectioned with a cryostat at a thickness of 5 µm. Immunohistofluorescence analysis was performed as described previously (27, 37) with monoclonal anti-PECAM-1 (MEC13.3; PharMingen) and polyclonal anti-cytokeratin (WSS; Dako). Immune complexes were detected with secondary antibodies labeled with Alexa 546 or Alexa 488 (each at a 1:2,000 dilution). The specimens were examined with a fluorescence microscope and photographed.
In situ hybridization. Tissue was fixed with 4% paraformaldehyde in phosphate-buffered saline, embedded in paraffin, and sectioned at a thickness of 5 µm. Riboprobes specific for Fbxw8 or Tpbp mRNAs were synthesized with a DIG RNA labeling kit (Roche). In situ hybridization was performed with the Ventana HX system as described previously (37). Sections were counterstained with Nuclear Fast Red (Ventana).
Preparation of MEFs. Primary mouse embryonic fibroblasts (MEFs) were obtained from E13.5 embryos and cultured as previously described (26). For biochemical analysis, the cells were plated in 10-cm dishes at a density of 2 x 106 cells per dish.
Plasmids, transfection, immunoprecipitation, and immunoblot analysis. Mouse cDNAs for Fbxw5, Fbxw8, and Fbxw8 deletion mutants were subcloned into the p3xFLAG-CMV 7.1 vector (Sigma). HEK293T cells were transfected with the resulting plasmids by the calcium phosphate method and cultured for 48 h before analysis. For retrovirus production, full-length mouse Cul1, Cul2, and Cul7 cDNAs were each subcloned into the pMX-puro II-U6-3xFLAG vector (21). The resulting plasmids were introduced into Plat-E cells by transfection with the Fu-Gene reagent (Roche) to generate recombinant retroviruses. MEFs were infected with the recombinant retroviruses and subjected to selection for 3 days in medium containing puromycin (10 µg/ml). The surviving cells were then isolated, lysed in a solution containing 0.5% Triton X-100, and subjected to immunoprecipitation with anti-FLAG as described previously (15). Embryos, placenta, and adult mouse tissue samples were lysed in radioimmunoprecipitation assay buffer and subjected to immunoprecipitation and immunoblot analysis as described previously (27, 37).
RNA interference (RNAi). The pMX-puro II-U6/shRNA vector was constructed as described previously (21). The DNA for the short hairpin RNA (shRNA) encoded a 21-nucleotide hairpin sequence specific to the mRNA target, with a loop sequence (5'-TTCAAGAGA-3') separating the two complementary domains, and it contained a tract of five T nucleotides to terminate transcription. The hairpin sequences specific for mouse Cul7 (mCul7-1 and mCul7-2) and enhanced green fluorescent protein (EGFP; Clontech) mRNAs corresponded to nucleotides 3022 to 3042 (mCul7-1), 4714 to 4734 (mCul7-2), and 126 to 146 (EGFP) of the respective coding regions. Recombinant retroviruses were produced and used to infect MEFs as described above. After selection in medium containing puromycin (10 µg/ml), cells stably expressing the shRNA were pooled for experiments.
| RESULTS |
|---|
|
|
|---|
|
We examined embryos from Fbxw8+/ intercrosses at various developmental stages to determine the time at which Fbxw8/ embryos become abnormal. All Fbxw8/ embryos were still recoverable at E11.5, whereas some of them were already dead or had begun to degenerate by E12.5 (Table 1). The number of live Fbxw8/ embryos was reduced to about one-half of that of wild-type littermates by E15.5. Growth retardation of homozygous mutant embryos and a reduction in size of the corresponding placentas were also apparent as early as E12.5 but became more obvious at later stages of gestation (Fig. 2A). The intrauterine growth retardation of Fbxw8/ embryos was reminiscent of that apparent for Cul7/ mice (4). About two-thirds of Fbxw8/ embryos eventually died in utero, with the remaining one-third being born alive. The Fbxw8/ neonates were smaller than their wild-type littermates, however, and remained so throughout postnatal life (Fig. 2B). No other gross abnormality was apparent in adult Fbxw8/ mice, and these animals did not die prematurely or show predisposition to cancer.
|
The placenta of Fbxw8/ embryos is grossly abnormal (Fig. 2A). The mouse placenta comprises four layers: the decidual layer, trophoblast giant cell layer, spongiotrophoblast layer, and labyrinth layer (1, 32). Hematoxylin-eosin staining of the placenta of E12.5 embryos revealed that the border of the spongiotrophoblast layer and labyrinth layer was unclear in the Fbxw8/ placenta, whereas the decidual and trophoblast giant cell layers of the Fbwx8/ placenta appeared normal (Fig. 3A and B).Similar differences between the placentas of wild-type and mutant embryos were also apparent at later gestational stages (data not shown). The placenta of some Fbxw8/ embryos also manifested irregular dilation of vessels in the labyrinth layer (Fig. 3B). In situ hybridization analysis of the mRNA for the spongiotrophoblast-specific marker Tpbp (1, 4) also revealed that the spongiotrophoblast layer of the Fbxw8/ placenta was reduced in thickness compared with that of the wild-type placenta (Fig. 3C and D). Irregular protrusion of spongiotrophoblasts into the labyrinth layer was also observed in the placenta of mutant embryos (Fig. 3D). Expression of the gene for PL-1, a marker for trophoblast giant cells (1), and of that for GCM1, a marker for the labyrinth layer (3), did not appear to be affected by the Fbxw8 mutation (data not shown). Immunohistofluorescence staining of the placenta of wild-type and Fbxw8/ embryos with antibodies to cytokeratin, a marker for trophoblast lineage cells in the spongiotrophoblast and labyrinth layers, and with antibodies to PECAM-1, a marker for endothelial cells in the labyrinth layer, yielded results consistent with those of in situ hybridization analysis of Tpbp mRNA (Fig. 4). These various data thus indicate that development of the spongiotrophoblast layer is impaired in Fbxw8/ mice.
|
|
To investigate whether the maternal Fbxw8 mutation affected the placental phenotype of Fbxw8/ embryos, we compared crosses of Fbxw8+/ females and Fbxw8+/ males with those of Fbxw8/ females and Fbxw8+/ males (Fig. 5). (All other analyses in this study were performed with embryos produced from Fbxw8+/ intercrosses.) Histological analysis of the placenta in pregnant females revealed that those of Fbxw8+/+ and Fbxw8+/ embryos developed normally, whereas that of Fbxw8/ embryos was defective, regardless of the maternal Fbxw8 genotype. The placental phenotype thus depends solely on the fetal genotype.
|
|
We investigated
the regions of Fbxw8 that mediate the interactions with Cul1 and Cul7
by generating a series of deletion mutants of Fbxw8 tagged at their
NH2 termini with the 3x FLAG epitope (Fig.
6C). Lysates of HEK293T
cells expressing these various mutant proteins were then subjected to
coimmunoprecipitation analysis with anti-FLAG (Fig.
6D). Full-length Fbxw8
interacted with both endogenous Cul1 and Cul7, whereas Fbxw5, another
Fbxw-type F-box protein, associated with Cul1 but not with Cul7. A
mutant of Fbxw8 that lacks the F-box domain (
F) retained the
ability to interact with Cul7, but it failed to associate with Cul1.
Conversely, deletion mutants that lack portions of the region of Fbxw8
containing the WD40 domains (
WD1,
WD2, or
WD3) or NH2-terminal region (
N) failed to
bind to Cul7 but retained the ability to interact with Cul1. A deletion
mutant that lacks the linker region (the region between the F-box
domain and the first WD40 domain) did not interact with either Cul1 or
Cul7. We also examined the binding of Skp1 to the Fbxw8 mutants and
found that Skp1 bound to the same mutants as did Cul1. These results
suggest that Fbxw8 binds to Cul1 via Skp1, as do other F-box proteins,
whereas Fbxw8 interacts with Cul7 mainly through its central and
COOH-terminal regions, not through its F-box domain, in an
Skp1-independent manner.
Given that Fbxw8 interacts with both Cul1 and Cul7, we hypothesized that a single Fbxw8 molecule might bind to both Cul1 and Cul7 simultaneously. To test this hypothesis, we expressed 3x FLAG-tagged Cul1 in Fbxw8+/+ or Fbxw8/ MEFs and then subjected cell lysates to coimmunoprecipitation analysis with anti-FLAG (Fig. 7A). We also expressed 3x FLAG-tagged Cul2 as a control. Exogenous Cul1 formed a complex with endogenous Cul7 as well as with Fbxw8, Skp1, and Rbx1 in Fbxw8+/+ MEFs, whereas the interaction between Cul1 and Cul7 was not detected in Fbxw8/ MEFs. Exogenous Cul2 associated with neither Cul7 nor Skp1. To substantiate these results, we performed reciprocal coimmunoprecipitation experiments with MEFs expressing 3x FLAG-tagged Cul7 or Cul2 (Fig. 7B). Exogenous Cul7 interacted with Cul1 as well as with Fbxw8, Skp1, and Rbx1 in Fbxw8+/+ MEFs. In contrast, the association of Skp1 and Cul1 with Cul7 was not detected in Fbxw8/ MEFs. These results indicate that Cul7 forms a complex with Cul1 only in cells that express Fbxw8. In addition, both Cul1 and Cul7 bound to Rbx1 even in Fbxw8/ cells in which the Cul1-Cul7 interaction was lost (Fig. 7), suggesting that both Cul1 and Cul7 interact with Rbx1 independently. Together with the results obtained with the deletion mutants of Fbxw8 (Fig. 6D), these data suggest that an Rbx1-Cul1-Skp1-Fbxw8-Cul7-Rbx1 complex forms in cells (Fig. 8). Furthermore, this complex likely plays an essential role in normal placental development.
|
|
| DISCUSSION |
|---|
|
|
|---|
Fbxw8 is unstable and undetectable in Cul7/ mice (4). We have now shown that Fbxw8 is also undetectable in MEFs depleted of Cul7 by RNAi, suggesting that Cul7 plays a chaperone-like role in stabilizing Fbxw8 through formation of a stable Cul1-Fbxw8-Cul7 complex. In contrast, Cul7 expression was unaffected by the loss of Fbxw8 in the present study. The phenotype of Cul7/ mice thus likely reflects the loss of Fbxw8 function as well as the loss of Cul7 function that is independent of Fbxw8 (Fig. 8).
The Cul1-Fbxw8-Cul7 complex is likely to contain at least two molecules of Rbx1, which is thought to associate directly with the E2 Cdc34. To date, several types of E3 or E3 complex are known to contain two RING finger domains for E2 binding. For example, Parkin contains two RING finger domains (19, 29, 34), both of which are indispensable for its E3 activity (19). BRCA1 and BARD1, both of which contain a single RING finger domain, dimerize to exert E3 activity (14). These observations suggest that two RING finger domains might also be required for maximal activation of E3 activity in the Cul1-Fbxw8-Cul7 complex. In 3-M syndrome patients who harbor mutations in Cul7, some mutations are located in the exon that encodes the cullin homology domain and result in impaired binding to Rbx1 (18). In addition, F-box proteins such as mammalian ß-TrCP1 and ß-TrCP2 and Schizosaccharomyces pombe Pop1p and Pop2p form homo- or heterodimers to achieve efficient ubiquitylation of their substrate proteins or to generate combinatorial diversity (25, 33, 35), suggesting the possibility that Cul1 incorporated in the SCF complex might form a dimer through dimerization of F-box proteins. Cul7 also forms a dimer with the related protein Parc (34). These data suggest that cullin-based E3s generally exist as homo- or heterodimeric complexes.
The expression of Fbxw8 is largely restricted to the placenta, whereas Cul7 is expressed not only in the embryo and the placenta but also in various tissues of adult mice and humans (18, 36). A comparison of the phenotypes of Fbxw8/ mice (this study) and Cul7/ mice (4) is summarized in Table 2. Consistent with the tissue distributions of these proteins, the abnormalities in Fbxw8/ mice appear to be restricted to the placenta, whereas those in Cul7/ mice also involve other tissues. Both types of mice manifest abnormal development of the spongiotrophoblast and labyrinth layers of the placenta. During placental development, trophectodermal cells distant from the inner cell mass of the blastocyst stop dividing but undergo endoduplication of their DNA, resulting in the formation of polyploid trophoblast giant cells. Trophectodermal cells overlying the inner cell mass continue to proliferate to form extraembryonic ectoderm and the ectoplacental cone of the early postimplantation conceptus. After chorioallantoic fusion in the mouse at E8.5, chorionic ectodermal cells derived from extraembryonic ectoderm differentiate into syncytiotrophoblasts to form the labyrinth in concert with fetal blood vessels, and ectoplacental cone cells develop into spongiotrophoblasts (1, 8-10, 32). The labyrinth is essential for gas exchange and nutrition transfer between the maternal and fetal circulation (9, 10, 32). Our data now suggest that the Cul1-Fbxw8-Cul7 complex plays an essential role in the mid- to late stage of placental development, and that the embryonic death of Fbxw8/ mice results from inappropriate development of the placenta. The less severe placental phenotype of Cul7/ mice, compared with that of Fbxw8/ mice, might be attributable to residual expression of Fbxw8 in Cul7/ mice. In contrast, the maternal decidua and trophoblast giant cells appeared unaffected in Fbxw8/ mice, whereas Cul7/ mice exhibit a reduced number of trophoblast giant cells and an underdeveloped decidual layer (4), suggesting that Cul7 contributes to the growth of trophoblast giant cells and differentiation of the maternal decidua in an Fbxw8-independent manner.
|
20% of
Cul7/ mice
exhibit hypodermal hemorrhage at late gestational ages
(4). These phenotypes were
not observed in
Fbxw8/
mice, again suggesting that Cul7 has Fbxw8-dependent and -independent
functions. The latter functions might be mediated by substrate
recognition subunits other than Fbxw8 that associate with Cul7 to form
an E3 ligase or by ubiquitylation-independent activity of Cul7. Cul7
was originally identified as a binding partner for the large T antigen
of simian virus 40, and it contains a BH3 domain in its COOH-terminal
region, implicating Cul7 in cellular transformation and apoptosis
(2,
24,
36). The phenotypic
differences between
Fbxw8/ mice
and Cul7/
mice are thus likely attributable to the different expression patterns
of the corresponding proteins and to Cul7-specific functions not
related to Fbxw8-mediated ubiquitylation.
| ACKNOWLEDGMENTS |
|---|
This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from the Human Frontier Science Program.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Ali,
S. H., J. S. Kasper, T. Arai, and J. A.
DeCaprio. 2004. Cul7/p185/p193 binding to simian virus
40 large T antigen has a role in cellular transformation.J. Virol.
78:2749-2757.
3. Anson-Cartwright, L., K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini, and J. C. Cross. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311-314.[CrossRef][Medline]
4. Arai,
T., J. S. Kasper, J. R. Skaar, S. H. Ali,
C. Takahashi, and J. A. DeCaprio. 2003.
Targeted disruption of p185/Cul7 gene results in abnormal vascular
morphogenesis. Proc. Natl. Acad. Sci. USA
100:9855-9860.
5. Bessho,
Y., R. Sakata, S. Komatsu, K. Shiota, S. Yamada, and R. Kageyama.2001
. Dynamic expression and essential functions of Hes7
in somite segmentation. Genes Dev.
15:2642-2647.
6. Cardozo, T., and M. Pagano. 2004. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell. Biol. 5:739-751.[CrossRef][Medline]
7. Cenciarelli, C., D. S. Chiaur, D. Guardavaccaro, W. Parks, M. Vidal, and M. Pagano. 1999. Identification of a family of human F-box proteins. Curr. Biol. 9:1177-1179.[CrossRef][Medline]
8. Cross, J. C. 2005. How to make a placenta: mechanisms of trophoblast cell differentiation in mice-a review. Placenta 26:S3-9.[CrossRef][Medline]
9. Cross, J. C., D. Baczyk, N. Dobric, M. Hemberger, M. Hughes, D. G. Simmons, H. Yamamoto, and J. C. Kingdom.2003 . Genes, development and evolution of the placenta.Placenta 24:123-130.[CrossRef][Medline]
10. Cross, J. C., M. Hemberger, Y. Lu, T. Nozaki, K. Whiteley, M. Masutani, and S. L. Adamson.2002 . Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol. Cell. Endocrinol. 187:207-212.[CrossRef][Medline]
11. Dias,
D. C., G. Dolios, R. Wang, and Z. Q. Pan.2002
. CUL7: a DOC domain-containing cullin selectively
binds Skp1.Fbx29 to form an SCF-like complex. Proc. Natl. Acad.
Sci. USA
99:16601-16606.
12. Furukawa, M., Y. J. He, C. Borchers, and Y. Xiong.2003 . Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat. Cell Biol. 5:1001-1007.[CrossRef][Medline]
13. Guardavaccaro, D., and M. Pagano. 2004. Oncogenic aberrations of cullin-dependent ubiquitin ligases. Oncogene 23:2037-2049.[CrossRef][Medline]
14. Hashizume,
R., M. Fukuda, I. Maeda, H. Nishikawa, D. Oyake, Y. Yabuki, H. Ogata,
and T. Ohta. 2001. The RING heterodimer BRCA1-BARD1 is
a ubiquitin ligase inactivated by a breast cancer-derived mutation.J. Biol. Chem.
276:14537-14540.
15. Hatakeyama,
S., M. Kitagawa, K. Nakayama, M. Shirane, M. Matsumoto, K. Hattori, H.
Higashi, H. Nakano, K. Okumura, K. Onoe, R. A. Good, and
K. I. Nakayama. 1999. Ubiquitin-dependent
degradation of I
B
is mediated by a ubiquitin ligase
Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci.
USA
96:3859-3863.
16. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system.Annu. Rev. Biochem. 67:425-479.[CrossRef][Medline]
17. Hicke, L. 2001. Protein regulation by monoubiquitin.Nat. Rev. Mol. Cell. Biol. 2:195-201.[CrossRef][Medline]
18. Huber, C., D. Dias-Santagata, A. Glaser, J. O'Sullivan, R. Brauner, K. Wu, X. Xu, K. Pearce, R. Wang, M. L. Uzielli, N. Dagoneau, W. Chemaitilly, A. Superti-Furga, H. D. Santos, A. Megarbane, G. Morin, G. Gillessen-Kaesbach, R. Hennekam, I. V. Burgt, G. C. Black, P. E. Clayton, A. Read, M. L. Merrer, P. J. Scambler, A. Munnich, Z. Q. Pan, R. Winter, and V. Cormier-Daire.2005 . Identification of mutations in CUL7 in 3-M syndrome.Nat. Genet. 37:1119-1124.[CrossRef][Medline]
19. Imai,
Y., M. Soda, and R. Takahashi. 2000. Parkin suppresses
unfolded protein stress-induced cell death through its E3
ubiquitin-protein ligase activity. J. Biol.
Chem.
275:35661-35664.
20. Jin,
J., T. Cardozo, R. C. Lovering, S. J. Elledge, M.
Pagano, and J. W. Harper. 2004. Systematic
analysis and nomenclature of mammalian F-box proteins. Genes
Dev.
18:2573-2580.
21. Kamura, T., T. Hara, M. Matsumoto, N. Ishida, F. Okumura, S. Hatakeyama, M. Yoshida, K. Nakayama, and K. I. Nakayama.2004 . Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase. Nat. Cell Biol. 6:1229-1235.[CrossRef][Medline]
22. Kamura,
T., K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C.
Conaway, J. W. Conaway, and K. I. Nakayama.2004
. VHL-box and SOCS-box domains determine binding
specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.Genes Dev.
18:3055-3065.
23. Kipreos, E. T., and M. Pagano. 2000. The F-box protein family. Genome Biol. 1:REVIEWS3002.[Medline]
24. Kohrman,
D. C., and M. J. Imperiale. 1992.
Simian virus 40 large T antigen stably complexes with a 185-kilodalton
host protein. J. Virol.
66:1752-1760.
25. Kominami, K., I. Ochotorena, and T. Toda. 1998. Two F-box/WD-repeat proteins Pop1 and Pop2 form hetero- and homo-complexes together with cullin-1 in the fission yeast SCF (Skp1-Cullin-1-F-box) ubiquitin ligase. Genes Cells 3:721-735.[Abstract]
26. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K. I. Nakayama.1996 . Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.[CrossRef][Medline]
27. Nakayama, K., H. Nagahama, Y. A. Minamishima, M. Matsumoto, I. Nakamichi, K. Kitagawa, M. Shirane, R. Tsunematsu, T. Tsukiyama, N. Ishida, M. Kitagawa, K. I. Nakayama, and S. Hatakeyama. 2000. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication.EMBO J. 19:2069-2081.[CrossRef][Medline]
28. Nakayama, K. I., and K. Nakayama. 2005. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16:323-333.[CrossRef][Medline]
29. Nikolaev, A. Y., M. Li, N. Puskas, J. Qin, and W. Gu.2003 . Parc: a cytoplasmic anchor for p53.Cell 112:29-40.[CrossRef][Medline]
30. Petroski, M. D., and R. J. Deshaies. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell. Biol. 6:9-20.[CrossRef][Medline]
31. Pintard, L., J. H. Willis, A. Willems, J. L. Johnson, M. Srayko, T. Kurz, S. Glaser, P. E. Mains, M. Tyers, B. Bowerman, and M. Peter. 2003. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase.Nature 425:311-316.[CrossRef][Medline]
32. Rossant, J., and J. C. Cross. 2001. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2:538-548.[Medline]
33. Seibert, V., C. Prohl, I. Schoultz, E. Rhee, R. Lopez, K. Abderazzaq, C. Zhou, and D. A. Wolf. 2002. Combinatorial diversity of fission yeast SCF ubiquitin ligases by homo- and heterooligomeric assemblies of the F-box proteins Pop1p and Pop2p.BMC Biochem. 3:22.[CrossRef][Medline]
34. Skaar,
J. R., T. Arai, and J. A. Decaprio.2005
. Dimerization of CUL7 and PARC is not required for
all CUL7 functions and mouse development. Mol. Cell.
Biol.
25:5579-5589.
35. Suzuki,
H., T. Chiba, T. Suzuki, T. Fujita, T. Ikenoue, M. Omata, K. Furuichi,
H. Shikama, and K. Tanaka. 2000. Homodimer of two
F-box proteins ßTrCP1 or ßTrCP2 binds to
I
B
for signal-dependent ubiquitination.J. Biol. Chem.
275:2877-2884.
36. Tsai,
S. C., K. B. Pasumarthi, L. Pajak, M. Franklin, B.
Patton, H. Wang, W. J. Henzel, J. T. Stults, and
L. J. Field. 2000. Simian virus 40 large T
antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis
protein in the cytoplasm. J. Biol. Chem.
275:3239-3246.
37. Tsunematsu,
R., K. Nakayama, Y. Oike, M. Nishiyama, N. Ishida, S. Hatakeyama, Y.
Bessho, R. Kageyama, T. Suda, and K. I. Nakayama.2004
. Mouse Fbw7/Sel-10/Cdc4 is required for notch
degradation during vascular development. J. Biol.
Chem.
279:9417-9423.
38. Weissman, A. M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2:169-178.[CrossRef][Medline]
39. Winston, J. T., D. M. Koepp, C. Zhu, S. J. Elledge, and J. W. Harper. 1999. A family of mammalian F-box proteins. Curr. Biol. 9:1180-1182.[CrossRef][Medline]
40. Xu, L., Y. Wei, J. Reboul, P. Vaglio, T. H. Shin, M. Vidal, S. J. Elledge, and J. W. Harper.2003 . BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3.Nature 425:316-321.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|